<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182020000300740</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v49n3.91341</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Principales enfermedades según el grupo sanguíneo en población mayor de 60 años en provincia de Cuenca (España)]]></article-title>
<article-title xml:lang="en"><![CDATA[Main diseases according to blood group in population over 60 years of age in the province of Cuenca (Spain)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Batanero-Hernán]]></surname>
<given-names><![CDATA[Ma. Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Escalera Izquierdo]]></surname>
<given-names><![CDATA[Begoña]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fresno Contreras]]></surname>
<given-names><![CDATA[María José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Chamorro]]></surname>
<given-names><![CDATA[Miguel Angel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Farmacéutica Comunitaria en Guadalajara  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Alcalá  ]]></institution>
<addr-line><![CDATA[Alcalá de Henares ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Farmacéutico Comunitario en Talavera de la Reina  ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Comunitario en Talavera de la Reina  ]]></institution>
<addr-line><![CDATA[Toledo ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2020</year>
</pub-date>
<volume>49</volume>
<numero>3</numero>
<fpage>740</fpage>
<lpage>758</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182020000300740&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182020000300740&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182020000300740&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Conocer la prevalencia de enfermedades según el grupo sanguíneo de la población estudiada en la provincia de Cuenca (España).  Métodos:  Estudio observacional, descriptivo, corte transversal y base poblacional. La muestra de 73 personas (39 varones, 34 mujeres), mayores de 60 años. Se identificaron todos los grupos sanguíneos, estudiándolos por edad y género.  Resultados:  Los porcentajes de grupos sanguíneos de la población estudiada por género son 42,6% (grupo A); 42,4% (O); 13% (B) y 1,4% (AB). Predomina el A+ (35,6%), seguido del O+ (27,4%). Se estudia la prevalencia de una determinada enfermedad en función del grupo sanguíneo. En este sentido, se detectan diferencias dentro de un mismo grupo, según el fator Rh. Los grupos Rh positivos padecen más de HTA, insomnio y depresión que los Rh negativos. Los grupos A y O padecen mayor aumento de colesterol que los del grupo B. Los del grupo O tienen más HTA que el resto y el O+ padece mayor porcentaje de anemia (Fe), mientras que los A+ anemia (B12). La osteoporosis es mayor en los grupos negativos que en los positivos, salvo en el grupo AB+.  Conclusiones:  El grupo sanguíneo con el que nacemos puede condicionar las enfermedades que padeceremos a lo largo de nuestra vida. El ser 0 podría predisponerlos a tener HTA, anemia (Fe), colesterol, enfermedades pulmonares e insomnio, mientras que el A depresión, anemia (B12) y problemas de próstata en varones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Objective:  To know the prevalence of diseases according to the blood group of the population studied in the province of Cuenca (Spain).  Methods:  An observational, descriptive, cross-sectional, and population-based study. The sample is 73 people (39 men and 34 women), over 60 years. All blood groups were identified, studying them by age and gender.  Results:  The percentages of blood groups of the population studied by gender are 42.6% (group A), 42.4% (O), 13% (B) and 1.4% (AB). A+ predominates (35.6%), followed by O+ (27.4%).The prevalence of a certain disease based on blood group is studied. In this sense, differences are detected within the same group, according to the Rh factor. Rh positive groups suffer more from hypertension, insomnia and depression than Rh negative groups. Groups A and 0 O suffer a greater increase in cholesterol than those of group B. Those in group 0 O have more hypertension than the rest and the 0O + suffer a higher percentage of anemia (Fe), while those A + anemia (B12). Osteoporosis is greater in the negative groups than in the positive ones, except in the AB + group.  Conclusions:  The blood group with which we are born can condition the diseases that we will suffer throughout our lives. Being 0 could predispose them to have hypertension, anemia (Fe), cholesterol, lung diseases and insomnia, while A could predispose them to have depression, anemia (B12) and prostate problems in men.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Grupo sanguíneo]]></kwd>
<kwd lng="es"><![CDATA[enfermedades]]></kwd>
<kwd lng="es"><![CDATA[población mayor de 60 años]]></kwd>
<kwd lng="en"><![CDATA[Blood group]]></kwd>
<kwd lng="en"><![CDATA[diseases]]></kwd>
<kwd lng="en"><![CDATA[population over 60]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landsteiner]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Popper]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Übertragung der Poliomyelitis acuta auf Affen]]></article-title>
<source><![CDATA[Zeitschrift für Immunitätsforschung und experimented Therapie]]></source>
<year>1909</year>
<volume>2</volume>
<page-range>377-90</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buzzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Karl Landsteiner y los grupos sanguíneos]]></article-title>
<source><![CDATA[ALMA Cultura y Medicina]]></source>
<year>2015</year>
<volume>1</volume>
<page-range>50-60</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manethová]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Janský Dr.]]></surname>
<given-names><![CDATA[Jan]]></given-names>
</name>
</person-group>
<source><![CDATA[descubridor de los grupos sanguíneos]]></source>
<year>2020</year>
<publisher-name><![CDATA[Radio Prague]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erb]]></surname>
<given-names><![CDATA[I.H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Blood groups classifications (A): Plea for uniformity]]></article-title>
<source><![CDATA[Canadian Medical Association Journal]]></source>
<year>1940</year>
<volume>42</volume>
<page-range>418-21</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murillo-Godínez]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Breve historia de la transfusión sanguínea]]></article-title>
<source><![CDATA[Revista de Hematología (México)]]></source>
<year>2019</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landsteiner]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wiener]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An agglutinable factor in human blood recognized by immune sera for rhesus blood]]></article-title>
<source><![CDATA[Proceedings of the Society for Experimental Biology and Medicine]]></source>
<year>1940</year>
<volume>43</volume>
<numero>223</numero>
<issue>223</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landsteiner]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wiener]]></surname>
<given-names><![CDATA[A.S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Studies on an agglutinogen (Rh) in human blood reacting with anti-rhesus sera and with human isoantibodis isoantibodis]]></article-title>
<source><![CDATA[The Journal of Experimental Medicine]]></source>
<year>1941</year>
<volume>74</volume>
<page-range>309-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Erythroblastosis Fetalis</collab>
<source><![CDATA[The Free Dictionary by Farlax]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[R.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grupo sanguíneo, alimentación y sobrepeso/ obesidad: Una miscelánea]]></article-title>
<source><![CDATA[Enfermería Global]]></source>
<year>2014</year>
<volume>36</volume>
<page-range>289-97</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Durán]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Piazza]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Trifone]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso sobre factores de riesgo de enfermedad cardiovascular en pediatría]]></article-title>
<source><![CDATA[Archivos Argentinos de Pediatría]]></source>
<year>2005</year>
<volume>103</volume>
<page-range>348-66</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olivares]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bustos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Lera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cortez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actitudes y prácticas sobre alimentación y actividad física en niños obesos y sus madres en Santiago]]></article-title>
<source><![CDATA[Revista Chilena de Nutrición]]></source>
<year>2006</year>
<volume>33</volume>
<page-range>170-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gargallo-Fernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ballesteros-Pomar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dietas heterodoxas]]></article-title>
<source><![CDATA[Revista Española de Obesidad]]></source>
<year>2006</year>
<volume>6</volume>
<page-range>75-87</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D'Adamo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Whitney]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Eat Right 4 Your Type]]></source>
<year>1996</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[G.P. Putnam's Sons]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rocco]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diet analysis: The ABO blood type diet]]></article-title>
<source><![CDATA[Journal of Complementary Medicine]]></source>
<year>2006</year>
<volume>2</volume>
<page-range>78-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bermúdez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Insuasty]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gamarra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grupo sanguíneo A y riesgo de cáncer gástrico en el hospital universitario de Santander (Bucaramanga, Colombia)]]></article-title>
<source><![CDATA[Acta Médica Colombiana]]></source>
<year>2006</year>
<volume>4</volume>
<page-range>400-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vento]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cainelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Controversias acerca de infeccion por helicobacter pylori y epidemiologia del cáncer gástrico]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Gaborone ]]></publisher-loc>
<publisher-name><![CDATA[University of Botswana School of Medicine]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<collab>La opinión</collab>
<source><![CDATA[El Correo de Zamora, ¿Qué tipo de sangre tiene más riesgo de sufrir un infarto?]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiao]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Yan]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hanping]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dongfeng]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Xiangfeng]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Relationship between the ABO blood group and the COVID-19 susceptibility]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nuevo descubrimiento: el factor Rh determina la resistencia a la enfermedad]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Janský]]></surname>
<given-names><![CDATA[Jan]]></given-names>
</name>
</person-group>
<source><![CDATA[descubridor de los grupos sanguíneos]]></source>
<year>2020</year>
<publisher-name><![CDATA[Radio Prague International]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
